SEC Form 4 · accession 0001250853-15-000045
IOVANCE BIOTHERAPEUTICS, INC. · IOVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Molly Henderson
Officer — Chief Financial Officer
Period of report
Jun 8, 2015
Accepted (ET)
Jun 10, 2015 · 6:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001425205
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $10.69 | Jun 8, 2015 | A | 200,000 | A | — | Jun 7, 2025 | Common stock | 200,000 | 200,000 | D |
Explanation of responses
- F1Stock Option vests as to 66,672 shares on June 8, 2016, and the remaining shares shall vest as to 16,666 shares at the end of each quarter over the following two years after June 8, 2016 provided Reporting Person remains in continuous employ of Issuer.